HOME >> MEDICINE >> NEWS
Antiplatelet drug found to reduce risk of recurrent heart attacks and stroke is cost-effective

ORLANDO -- The antiplatelet medicine clopidogrel is not only effective in reducing the risk of recurrent heart attack and stroke, it is also extremely cost-effective, according to data presented today by researchers from Emory University at the American Heart Association's Scientific Sessions.

"We have three separate investigations showing uniform results in both the short and long-term use of clopidogrel. Specifically, the use of clopidogrel in addition to aspirin produces a significant risk reduction in recurrent heart attack, stroke or cardiovascular death," says William Weintraub, M.D. FACC, Director, Emory Center for Outcomes Research in the Division of Cardiology, Department of Medicine, Emory University School of Medicine, who presented the data. "The study findings and the cost-effectiveness data suggest that at least one year of therapy with clopidogrel is an attractive value. In fact, we believe it should be the standard of care for this patient population."

The Emory University investigators analyzed the drug's cost-effectiveness ratio in two major clinical studies -- the CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Events) trial and the CREDO (Clopidogrel for the Reduction of Events During Observation) trial -- as well as a substudy of CURE, called PCI-CURE . Cost-effectiveness ratio is the incremental cost of using an intervention to obtain a unit of effectiveness (such as dollars per life-year gained) compared to another treatment or no treatment.

Based on CURE, the Emory researchers found that the cost-effectiveness ratio was $6,173 per life year gained. PCI-CURE, which evaluated people who received clopidogrel for up to one year after having an angioplasty or stent, demonstrated a cost-effectiveness ratio of $5,910 per life year gained. In CREDO, patients were given a dose of clopidogrel before having an angioplasty or stenting procedures and continued on clopidogrel therapy for up to one year. The cost-effect
'"/>

Contact: Sherry Baker
emoryheartnews@aol.com
404-377-1398
Emory University Health Sciences Center
12-Nov-2003


Page: 1 2

Related medicine news :

1. Antiplatelet drugs: comparison of clopidogrel with aspirin
2. Acupuncture found to lower elevations in blood pressure
3. Proteins found in urine of pregnant women could help diagnose preeclampsia
4. Potential drug target for treating cocaine abuse found
5. Similar results found in both older and younger patients undergoing weight-loss surgery
6. Infectious agent linked to mad cow disease found in organs other than the brain
7. Generation gap found in chronic pain
8. A site for sore eyes: New target for allergies found under the eyelid
9. Chemicals found in cherries may help fight diabetes
10. Thanks for the memories: cinematic portrayal of amnesia is profoundly misleading
11. Very high prevalence of virus linked to cervical cancer found in adolescent women

Post Your Comments:
(Date:3/3/2015)... Dr. Stephen Edgerton, a ... has achieved Accredited Member Status in the American ... this accomplishment after completing a rigorous credentialing process ... the submission of clinical cases for examination. ... up in Connecticut, Charlotte, North Carolina, Caracas, Venezuela ...
(Date:3/3/2015)... March 03, 2015 All ... website that focuses on providing an interactive directory ... and addiction treatment for clients ranging in ages ... on the site have a wide variety of ... disorders, severe learning disabilities, drug rehabilitation, failure to ...
(Date:3/2/2015)... Getting customers to discover a whole new world ... as the 31st annual Frozen Food Month kicks off. ... Refrigerated Foods Association (NFRA) to stimulate the awareness and ... delicious frozen selections and is thrilled to be part ... are crafted with simple ingredients, no preservatives or artificial ...
(Date:3/2/2015)... 02, 2015 Today the Brain Injury Association ... a time to recognize and support the more than 5.3 ... Each year BIAA leads the nation in observing Brain Injury ... of March. The theme for the 2015 to 2017 campaign ... a platform for educating the general public about the incidence ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to offer ... Analysts Inc and recently added to its catalogue. , ... 2018, the global radiation therapy equipment market is poised ... suggests a holistic analysis of the situation in the ... covers the top market trends. The publication uncovers data ...
Breaking Medicine News(10 mins):Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3
(Date:3/2/2015)... LAKES, N.J. , March 2, 2015 ... ), a leading global medical technology company, today announced ... San Diego -based medical technology company dedicated to ... The acquisition furthers BD,s position in helping address preventable ... BD and CRISI entered into an exclusive partnership in ...
(Date:3/2/2015)... 2015  Vivex Biomedical, Inc., a leading processor of ... announced today that it hired Lou Barnes ... Inc.   Vivex Biomedical formed UMTB Biomedical as a wholly-owned ... (UMTB) in November 2014. UMTB is the oldest tissue ... a twenty-five year veteran of the tissue banking industry, ...
(Date:3/2/2015)... CORTLANDT MANOR, N.Y. , March 2, 2015 /PRNewswire/ ... patients screened for CRC.   During CRC Awareness Month, we ... items throughout March. , Posters – ... seating areas , CRC Patient Brochures with Stand ... , Screening Reminder Post-its – to be put on/in ...
Breaking Medicine Technology:BD Acquires CRISI Medical Systems 2BD Acquires CRISI Medical Systems 3Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2
Cached News: